Ostinol and Bone Loss
The incidence of bone loss has become epidemic and you know it must be significant if pharmaceutical companies are touting their products in television commercials and magazine ads. We need to be aware that this epidemic of bone loss is not just in post-menopausal women, but in a very large number of men also.
Bone loss is complex, and its cause multi-factorial. The loss of estrogen, progesterone, and testosterone can be important factors, but so can deficiencies in vitamin D3, vitamin K2, calcium, magnesium, and boron.
Please be aware that the conventional treatment with the bisphosphonate drugs (Actonel and Fosamax) are fraught with serious side effects, including increased risk of fractures, the very reason you are prescribed the drug!
Bone loss is a big concern for all of us, but there are safer and more effective ways to prevent and treat this disorder. I have been excited about the use of an all-natural bioactive protein complex containing bone morphogenetic proteins (BMPs) in rebuilding bone.
The patients I have given Ostinol, the product containing the BMPs, have had very significant reversal of their disease. It does this by activating stem cells to grow new bone and cartilage tissue, and also enhances the immune system.
We use one 450 mg capsule daily for mild to moderate bone loss and two capsules for severe disease. If you have bone loss, please consider using this very safe and effective, non-prescription therapy, along with repleating vitamin D3, calcium, vitamin K2, and the bone-building hormone progesterone.
To order a supply of Ostinol, or any other supplements from COEM, send an e-mail to ORDERS@COEM.COM with the following information.
- Number and type of items you wish to order
- Credit Card Information (Type of Card, Card #, Exp. Date, CVV, Name of Card)
- If you are picking up your order at our office, please let us know as well
Please allow 5-7 business days to process your order.
Yours in health,
Allan D. Lieberman, M.D., F.A.A.E.M.
Center for Occupational & Environmental Medicine
February 10, 2015